Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950134-03-013031
Filing Date
2003-09-26
Accepted
2003-09-25 18:36:36
Documents
9
Period of Report
2003-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K c79690e10vk.htm 10-K 548254
3 EX-10.1 WAIVER AND AMENDMENT AGREEMENT c79690exv10w1.txt EX-10.1 5218
4 EX-10.21 AMENDMENT TO REVOLVING CREDIT AGREEMENT c79690exv10w21.txt EX-10.21 4766
5 EX-23.1 CONSENT OF GRANT THORNTON LLP c79690exv23w1.txt EX-23.1 1218
6 EX-31.1 CERTIFICATION PURSUANT TO SECTION 302 c79690exv31w1.txt EX-31.1 3650
7 EX-31.2 CERTIFICATION PURSUANT TO SECTION 302 c79690exv31w2.txt EX-31.2 3678
8 EX-32.1 CERTIFICATION PURSUANT TO SECTION 906 c79690exv32w1.txt EX-32.1 1469
9 EX-32.2 CERTIFICATION PURSUANT TO SECTION 906 c79690exv32w2.txt EX-32.2 1484
10 EX-99.1 RISK FACTORS c79690exv99w1.txt EX-99.1 19286
  Complete submission text file 0000950134-03-013031.txt   591777
Mailing Address
Business Address 3515 LYMAN BLVD CHASKA MN 55318-3051 6123684300
LIFECORE BIOMEDICAL INC (Filer) CIK: 0000028626 (see all company filings)

EIN.: 410948334 | State of Incorp.: MN | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-04136 | Film No.: 03910921
SIC: 2836 Biological Products, (No Diagnostic Substances)